Dr. Dennis Sayong Sula, MD

Dr. Sula practices at Munson Medical Center in Traverse City, Michigan, part of Munson Healthcare.

Dr. Sula's NPI, 1699781658, was assigned on July 31, 2006. Dr. Sula holds South Dakota license 5807.

Dr. Sula's primary practice is Munson Medical Center, at 1105 Sixth Street, Traverse City, MI 49684 in Grand Traverse County. The practice phone is (231) 935-5000.

Dr. Sula's primary practice is Munson Medical Center in Traverse City, Michigan, part of Munson Healthcare. Dr. Sula is also affiliated with Munson Healthcare Cadillac Hospital. The medical group on file is Munson Healthcare Endocrinology & Metabolism. Dmand AI also links Dr. Sula to 3 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sula practices, 6 sites in all. Vendor and product names are available with a free account.

Internal medicine is Dr. Sula's primary specialty in the NPI Registry, under taxonomy code 207R00000X. Dr. Sula is licensed in South Dakota.

CMS data shows 697 Medicare services from Dr. Sula across 5 procedure codes in 2024, for 136 Medicare patients. Medicare paid $65,781 for them.

CMS counts 136 Medicare patients who saw Dr. Sula in 2024. The largest group is 65 to 74, with 51 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 31% are also on Medicaid. Their average risk score is 2.47, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sula's median patient age at 69, with 39% women.

In 2024, Dr. Sula wrote 684 Medicare Part D claims for 148 patients. 74% of them were for generic drugs. CMS names the drug for 619 of them, across 19 drugs with 11 or more claims each, at $919,552 in total drug cost. In 2023, CMS named 544 claims across 15 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Sula for performance year 2024, reported as part of a group. Dr. Sula accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sula as offering telehealth.

CMS Open Payments shows 17 general payments to Dr. Sula from 6 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 94% of the total. Gilead Sciences, Inc. paid the most, $659.